INO — Inovio Pharmaceuticals Share News
0.000.00%
Last trade - 00:00- $92.76m
- $56.08m
- $0.07m
Inovio Pharmaceuticals Inc reports results for the quarter ended in June - Earnings Summary
Inovio Pharmaceuticals Inc expected to post a loss of $1.10 a share - Earnings Preview
Brief: Inovio Says EMA Certified Quality And Non-Clinical Data For Lead Candidate INO-3107
Brief: INOVIO Announces Appointment Of Steven Egge As Chief Commercial Officer
Inovio Pharmaceuticals Inc reports results for the quarter ended in March - Earnings Summary
Inovio Pharmaceuticals Inc expected to post a loss of 100 cents a share - Earnings Preview
Brief: Inovio Announces Pricing Of Approximately $36 Mln Underwritten Offering Of Common Stock And Pre-Funded Warrants
Inovio Pharmaceuticals Inc reports results for the quarter ended in December - Earnings Summary
Brief: Inovio Reports Fourth Quarter Results
Brief: Inovio Announces Effective Date Of 1-For-12 Reverse Stock Split
U.S. STOCKS ON THE MOVE-Crypto stocks, US insurers, EPAM Systems
U.S. STOCKS ON THE MOVE-Apple, Lamb Weston, Dyne Therapeutics
Inovio rises on Coherus collaboration for HPV-related cancer therapy development
Brief: Inovio Plans To Submit BLA For Ino-3107 In H2 2024 Under Accelerated Approval Program
Brief: Inovio Pharmaceuticals Inc Files For Mixed Shelf Of Up To $300 Million - SEC Filing
U.S. STOCKS ON THE MOVE-Hyatt Hotels, Walmart, Maxeon
U.S. STOCKS ON THE MOVE-Olema Pharma, Akamai Technologies, US banks
U.S. STOCKS ON THE MOVE-PepsiCo, Electronic Arts, Honeywell
Brief: Inovio Receives FDA Feedback That Data From Completed Phase 1/2 Trial Of INO-3107 Can Be Used To Submit A BLA Under Accelerated Approval Program